Ovalis, catheter company, raises $6.6M
Ovalis, a Mountain View, Calif. developer of catheter-based products for repairing cardiac defects, has raised around $6.6 million in Series B funding, according to a regulatory filing cited by PE Week. Return backers include Abbott Labs, De Novo Ventures and Latterell Venture Partners.
(Originally posted 1/16)
Next Story: UPDATE: Vantage Point closes Israel office, lets some staff go
Previous Story: RingCentral raises $6.25M to sell telecom services to businesses
